EN DE
Watch Nynomic AG for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Nynomic AG (M7U) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Nynomic AG stock €13.58, price €22.40, that is 39.4% below the price, quality 52 out of 100. Rating: strongly overvalued. Calculated from audited financials with 11 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Technology DE · ISIN DE000A0MSN11

NA Nynomic AG logo Some data Nov 8, 2026

Nynomic AG

M7U · XETRA
Solid, but very expensive

Our calculation puts a fair price 39% below what the stock costs today.

Low debt
Generates free cash flow
Quality 52/100
Thin margins · 3.4% net margin (TTM)
Some data
Fair value €13.58 · Strongly overvalued
Weak Growth (revenue 3y −7.5 %/yr in EUR)
Trails peers (5/14)
Narrow moat 31/100 · thin data
Watch Nynomic AG for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€54.40 €8.36 Fair Value €13.58 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.

How to read this chart

60‑month range €8.36 – €54.40 · fair‑value band €9.92 – €17.47 · the €22.40 price screens above the €13.58 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.

Follow Nynomic in your weekly email

Every Wednesday you see whether Nynomic is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Nynomic AG, together with its subsidiaries, manufactures and sells products for permanent, non-contact, and non-destructive optical measurement technology.

Show moreShow less

The company also supplies customized system solutions in the areas of control engineering, sensor technology, and laboratory automation or spectrometry; components and systems for industrial optical spectroscopy, including UV-VIS-NIR and Raman diode array spectroscopy with associated software solutions; and develops and manufactures optical measurement systems for various applications.

In addition, it provides spectrometers, light sources for UV, VIS, and NIR, as well as fibre optics or optical waveguides, accessories, and customer-specific products for OEM applications, as well as scientific market; optical measurement and control technology systems; process-integrated measurement technology solutions; and hardware and software systems for digital plant phenotyping and high-throughput screening fields.

Further, the company develops, produces, and distributes infrared measurement technology; development and manufacture of test and calibration equipment for cameras and multi-sensor systems; micro-incandescent lamps, lenses, and special lamps; and special fibres for optical measurement technology.

The company was formerly known as m-u-t AG and changed its name to Nynomic AG in August 2018. Nynomic AG was incorporated in 1995 and is headquartered in Wedel, Germany.

Stock analysis

Nynomic AG (M7U) currently trades at €22.40, while our model-based Fair Value estimate is €13.58, 39% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of €13.13 per share, and 0 of the 11 models we run sit above the €22.40 price.

Bear case: the Asset-Based group reads lowest at €3.66, and 11 of the 11 models stay below the price. Data coverage for this calculation is medium.

Scenario range: €9.92 (bear) to €17.47 (bull), the price of €22.40 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 52/100 (solid quality), in the Technology sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Nynomic AG reported revenue of €92.6M in FY2025 versus €105M in FY2021, a compound −3.1%/yr. Reported net income was −€704K in FY2025.

Key figures

Market cap €144M Micro · P/E ratio 44.8 · P/S ratio 1.64 · EPS (TTM) €0.5000 · Dividend yield 0.4% · Net margin 3.4% · Return on equity 3.9% · Return on assets (EBIT) 7.2% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 31 out of 100 (low confidence).

What moves the price

The share trades about 20% below its 52-week high and 168% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Technology peers we cover trades at −45% fair-value upside, at −39%, M7U screens cheaper than that median.

Fair Value models

Bear €9.92 Fair Value €13.58 Bull €17.47
Price €22.40 · Downside -39.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (€0.4288 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF €9.89 €12.63 €15.96 80
Growth DCF €9.92 €12.32 €15.07 78
Owner Earnings €8.00 €10.07 €12.59 76
All 11 models by family
DCF Models
FCF DCF €9.89 €12.63 €15.96 80
Owner Earnings €8.00 €10.07 €12.59 76
5Y Revenue Exit €9.75 €13.58 €18.34 71
5Y EBITDA Exit €10.86 €15.61 €21.02 73
10Y Revenue Exit €9.55 €12.68 €16.66 66
10Y EBITDA Exit €10.32 €13.87 €18.37 67
Multiples
EV/EBITDA €10.27 €13.87 €17.47 67
EV/Revenue €7.44 €10.85 €14.25 53
Asset-Based
NCAV (Graham) €2.41 €3.66 €4.57 54
Growth DCF
Growth DCF €9.92 €12.32 €15.07 78
Rev-Margin DCF €9.75 €13.66 €18.06 71

Open the full fair value analysis →

Quality Score breakdown

Overall quality 52/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 21
How much profit the company makes from its sales and capital
Quality Growth 16
Are margins and returns getting better?
Cashflow 49
Do the profits arrive as real cash?
Financial strength 84
Debt, balance sheet and risk of trouble
Investment 82
Does it invest with discipline instead of growing at any price?
Low Volatility 30
How calm the share price moves, does not count
Price momentum 77
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 86
Distance to the 52-week high, does not count
New shares 77
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−9.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−7.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.3%
Start year 2020 (pandemic). Over 10 years: +5.9% a year
Revenue growth 16 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.7%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
10.1% (2020) → −0.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+19.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about +17.0% a year for the price.

M7U screens overvalued: fair value 39% below the price. Compare with Keysight Technologies, Inc →

Compare Nynomic AG with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Scientific & Technical Instruments · 160 stocks

Beats the industry median on 5/14 measures
Overall it trails its industry peers.
Valuation
Quality Score 52 · Below median
Fair Value upside −39.4% · Below median
Profitability
Return on equity (12 months) 3.9% · Below median
Return on assets −0.5% · Bottom 25%
Net margin (12 months) 3.4% · Below median
Operating margin (12 months) 3.8% · Below median
Growth and dividend
Revenue growth (quarter YoY) 13.3% · Above median
Dividend yield (12 months) 0.4% · Bottom 25%
Balance sheet
Debt / equity 0.00× · Below median

Valuation Multiplesvs Scientific & Technical Instruments median · lower = cheaper

P/E (12 months) 44.8× · Pricier than median
P/B 1.67× · Cheaper than median
P/S (12 months) 1.64× · Cheaper than median
Price / free cash flow (fiscal year) 28.0× · Pricier than median
EV/EBITDA 16.7× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 0
FUTURE (revenue growth)67 · sector 47
PAST (return on equity)16 · sector 24
HEALTH (low debt)100 · sector 99
DIVIDEND (yield)9 · sector 20

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Scientific & Technical Instruments stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Garmin Ltd GRMN $285.57 $314.13 +10% vs M7U
Teledyne Technologies Incorporated TDY $618.60 $680.46 +10% vs M7U
MKS Inc MKSI $192.27 $199.16 +4% vs M7U
Cognex Corporation CGNX $47.78 $38.10 −20% vs M7U
Fortive Corporation FTV $65.37 $35.67 −45% vs M7U
Trimble Inc TRMB $54.11 $29.48 −46% vs M7U
Chroma ATE Inc 2360 1,250 TWD 607.12 TWD −51% vs M7U
Coherent Corp COHR $192.81 $92.93 −52% vs M7U
Keysight Technologies, Inc KEYS $272.13 $117.27 −57% vs M7U
AVIC Chengdu Aircraft Company 302132 ¥70.00 ¥12.60 −82% vs M7U

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Nynomic AG: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Nynomic AG Fair Value". https://www.fairvalue-calculator.com/stock/M7U

Frequently asked questions

Is Nynomic AG (M7U) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of €13.58 versus a price of €22.40, about 39% lower (overvalued).
What is the fair value of M7U?
Our model-based fair value for Nynomic AG is €13.58 (as of Nov 8, 2026), built from audited fundamentals. The current price: €22.40.
What is the quality score of M7U?
Nynomic AG has a Quality Score of 52/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Nynomic AG (M7U)?
Our model-based price target is the fair value of €13.58 (as of Nov 8, 2026) from 11 valuation models. Cautious scenario €9.92, optimistic scenario €17.47. It is a calculation from audited fundamentals, not an analyst target.
What is the Nynomic AG stock forecast for 2026?
Our models put fair value at €13.58, about 39% lower versus a price of €22.40 (overvalued). Cautious scenario €9.92, optimistic scenario €17.47. The calculation is refreshed regularly with new filings.
What is the revenue of Nynomic AG (M7U)?
Nynomic AG reported trailing-twelve-month revenue of about €98.2M (latest available figure, as of Nov 8, 2026).
Does Nynomic AG pay a dividend?
Nynomic AG currently shows a dividend yield of 0.44% relative to its recent price (as of Nov 8, 2026).
How much is the dividend of Nynomic AG (M7U)?
Nynomic AG has a dividend yield of 0.4%.
What growth is priced into Nynomic AG (M7U)?
For today's price to be fair in a discounted-cash-flow model, Nynomic AG would have to grow free cash flow by +19.6 % per year for five years (discount rate 12.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +3.3 % per year. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of M7U use?
Our models discount Nynomic AG at 12.6 %: a base by market capitalisation (micro), damped by beta 1.02, country premium for Germany. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Nynomic AG that is +19.6 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (12.6 %) and the same formula as our fair value.
How much growth has Nynomic AG (M7U) delivered so far?
Over the past 5 years revenue at Nynomic AG grew +3.3 % a year. The price currently implies free-cash-flow growth of +19.6 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Nynomic AG (M7U) growing?
The median revenue growth in the sector is +11.5 % a year. That is the yardstick for the growth priced into Nynomic AG (+19.6 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Nynomic AG (M7U)?
The free-cash-flow yield on the price is 3.90 %: that much free cash flow Nynomic AG produces per unit of market value. When it exceeds the discount rate of our models (12.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Nynomic AG (M7U)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Nynomic AG it is €13.58 per share (as of Nov 8, 2026), against a price of €22.40. It is the blended result of 11 valuation models in 4 families (DCF Models, Multiples, Asset-Based, Growth DCF).
Is Nynomic AG stock overvalued or undervalued in 2026?
As of Nov 8, 2026, M7U trades above its calculated fair value: price €22.40, fair value €13.58, a gap of about −39% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of M7U?
No. The price is what the market pays today (€22.40); the fair value is what the company's own numbers justify (€13.58). For Nynomic AG the two are €8.82 per share apart. That gap is exactly why we show both numbers side by side.
How much is Nynomic AG worth?
The market values Nynomic AG at about €144M (market capitalisation, as of Nov 8, 2026). Per share that is €22.40; our models calculate a fair value of €13.58 per share.
What do the bullish and bearish scenarios say about M7U?
Our models span a range for Nynomic AG: cautious scenario €9.92, base €13.58, optimistic €17.47 per share (as of Nov 8, 2026, price €22.40). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of M7U?
Nynomic AG trades at a price-to-earnings ratio of 44.8 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €13.58 is built from several models across several years. Other multiples: P/B 1.7, P/S 1.6, EV/EBITDA 16.7.
How solid is the balance sheet of Nynomic AG (M7U)?
Balance-sheet figures for Nynomic AG (as of Nov 8, 2026): return on equity 3.9%, debt of 0.00 per unit of equity. They feed the Quality Score of 52/100, which measures business quality independently of the share price.
How far is M7U from its 52-week high?
Nynomic AG trades at €22.40, about 20% below its 52-week high of €28.10 and 168% above the low of €8.36 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of €13.58 is for.
Which stocks are comparable to Nynomic AG?
From the same area (Technology) we also value Keysight Technologies, Inc, Garmin Ltd, Coherent Corp, Teledyne Technologies Incorporated, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Nynomic AG stock attractive at the current price?
The data as of Nov 8, 2026: price €22.40, calculated fair value €13.58 (−39%), Quality Score 52/100, from 11 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of M7U calculated?
We run Nynomic AG through 11 models from 4 families: DCF Models, Multiples, Asset-Based, Growth DCF. Every model gets the same audited fundamentals; the fair value of €13.58 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Nynomic AG itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Nynomic AG (M7U)?
The closing price on Nov 6, 2026 was €22.40. Our model-based fair value is €13.58, about 39% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Nynomic AG right now?
The price sits above even our optimistic bull case (€17.47). The favourable scenario is already priced in. Solid but not exceptional quality (52/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of Nynomic AG

How large is the market capitalisation of Nynomic AG (M7U)?
The market capitalisation of Nynomic AG is €144M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Nynomic AG (M7U)?
The price-to-sales ratio of Nynomic AG is 1.64 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Nynomic AG (M7U)?
Earnings per share at Nynomic AG are €0.5000 (price ÷ EPS = P/E 44.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Nynomic AG (M7U)?
The dividend yield of Nynomic AG is 0.4% (payout 19.9%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Nynomic AG (M7U)?
The net margin of Nynomic AG is 3.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Nynomic AG (M7U)?
The return on equity (ROE) of Nynomic AG is 3.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Nynomic AG (M7U)?
On an EBIT basis the return on assets of Nynomic AG is 7.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Nynomic AG (M7U)?
The operating margin of Nynomic AG is 3.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Nynomic AG (M7U)?
Revenue at Nynomic AG is growing +13.3% versus a year earlier (3y avg −7.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Nynomic AG (M7U)?
Earnings per share at Nynomic AG are growing −1.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Nynomic AG (M7U) carry?
The net debt of Nynomic AG is €3.4M (fiscal year 2025, ≈ 0.6 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Nynomic AG in the live analysis

One click puts Nynomic AG on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.